CoChat

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Future mechanistic strategies for tackling fibrosis–an unmet need in liver disease

Open access
Fallowfield, Jonathan A · 2015 · Clinical Medicine

Abstract

Standardised mortality rates for liver disease in the UK have increased 400% since 1970. However, evidence from a large number of animal models and clinical trials indicates that liver fibrosis and even cirrhosis are potentially reversible if the underlying cause can be successfully removed. Nevertheless, in a significant number of patients cure of the underlying disease may not result in fibrosis regression, and no antifibrotic drug has been licenced by the United States Food and Drug Administration or the European Medicines Agency. Dissection of the mechanistic pathways and regulatory factors that characterise matrix remodelling and architectural repair during fibrosis regression are revealing novel therapeutic approaches to induce liver repair. Points of attack in the fibrotic cascade include promoting the loss of hepatic myofibroblasts, inhibiting profibrogenic properties of myofibroblasts, stimulating degradation of accumulated liver scar tissue, targeting the immune response, and cell-based therapies. Therapeutic candidates are now being evaluated in early-phase human trials but translation into the clinic will require careful patient selection and stratification, and the definition and validation of clinically meaningful endpoints.

Overview

Integrity signals

Registry

Crossref · 10.7861/clinmedicine.15-6-s83

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Research works printed but not linked: 1

  1. Iredale, 1998, Mechanisms of spontaneous resolution of rat liver fibrosis, Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest, 102, 535

Cited by

See all 15

Metadata

Authors
Fallowfield, J. A.
Affiliations
Centre for Inflammation Research (GB)
Corresponding author
Fallowfield, Jonathan A
Venue
Clinical Medicine
Publisher
Elsevier BV
Published
2015-12
Volume
15
Issue
6
Pages
s83-s87
ISSN
1470-2118 (ISSN-L)
OpenAlex
W2183791618
Cited by
15
References
31
Citations by year
2025: 2 · 2024: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 4
FWCI
1.18
Type
journal article
Language
en
Open access
Licence
Locations
  • Clinical Medicine (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
Academy of Medical Sciences (AMS-CSF3-Fallowfield)
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
Keywords
liver fibrosis, antifibrotic therapy, fibrosis regression, myofibroblasts, extracellular matrix remodeling, liver repair, liver cirrhosis, cell therapy, fibrosis biomarkers, clinical trial endpoints, patient selection
MeSH terms
Humans, Liver Cirrhosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Future mechanistic strategies for tackling fibrosis–an unmet need in liver disease. https://app.cochat.ai/papers/10.7861/clinmedicine.15-6-s83
The paper
Fallowfield, J. A. (2015). Future mechanistic strategies for tackling fibrosis–an unmet need in liver disease. Clinical Medicine. https://doi.org/10.7861/clinmedicine.15-6-s83

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.